Stay updated on QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedThe QUADRA clinical trial record for niraparib in patients with previously treated ovarian cancer is displayed, including study design, eligibility criteria, participating locations, outcome measures, and related documents.SummaryDifference76%

- Check13 days agoChange DetectedThe site footer revision label changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces an NIH-wide terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the study record remains unavailable on the 403 error page.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study details with a basic error screen and a revision note.SummaryDifference18%

Stay in the know with updates to QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.